U.S. Markets closed
  • S&P Futures

    4,130.75
    -2.00 (-0.05%)
     
  • Dow Futures

    33,538.00
    -32.00 (-0.10%)
     
  • Nasdaq Futures

    13,968.00
    -7.75 (-0.06%)
     
  • Russell 2000 Futures

    2,223.00
    -1.90 (-0.09%)
     
  • Crude Oil

    60.54
    +0.36 (+0.60%)
     
  • Gold

    1,747.10
    -0.50 (-0.03%)
     
  • Silver

    25.42
    -0.01 (-0.02%)
     
  • EUR/USD

    1.1957
    +0.0003 (+0.0239%)
     
  • 10-Yr Bond

    1.6230
    -0.0520 (-3.10%)
     
  • Vix

    16.65
    -0.26 (-1.54%)
     
  • GBP/USD

    1.3760
    +0.0007 (+0.0537%)
     
  • USD/JPY

    108.9120
    -0.1360 (-0.1247%)
     
  • BTC-USD

    63,523.75
    +3,420.11 (+5.69%)
     
  • CMC Crypto 200

    1,359.18
    +65.19 (+5.04%)
     
  • FTSE 100

    6,890.49
    +1.37 (+0.02%)
     
  • Nikkei 225

    29,751.61
    +212.91 (+0.72%)
     

Should Forward Pharma (FWP) Be On Your Radar Now?

Zacks Equity Research

It can be very difficult to find companies that are both flying under the radar, and still might have potential for gains. Many times, stocks are off investors’ radar screens for a reason, though there are some hidden gems that could be worth uncovering by those with a high risk tolerance.   

One way to find these underappreciated stocks is by looking at companies that haven’t seen their share prices move higher lately, but have observed analysts raising earnings estimates for their stock. This trend could signal that investors haven’t quite embraced the rising estimate story yet, but that the potential for a big move higher is definitely there.

One such company that looks well positioned for a solid gain, but has been overlooked by investors lately, is Forward Pharma A/S FWP. This Medical - Drugs stock has actually seen estimates rise over the past month for the current fiscal year by about 2.3%. But that is not yet reflected in its price, as the stock lost 30.1% over the same time frame.

Forward Pharma A/S Price and Consensus

 

Forward Pharma A/S Price and Consensus | Forward Pharma A/S Quote

You should not be concerned about the price remaining muted going forward. This year’s expected earnings growth over the prior year is 68.6%, which should ultimately translate into price appreciation.

And if this isn’t enough, FWP currently carries a Zacks Rank #2 (Buy) which further underscores the potential for its outperformance (See the performance of Zacks' portfolios and strategies here: About Zacks Performance). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

So if you are looking for a stock flying under-the-radar that is well-equipped to bounce down the road, make sure to consider Forward Pharma. Solid estimate revisions and an impressive Zacks Rank suggest that better days may be ahead for FWP and that now might be an interesting buying opportunity.

Zacks' Hidden Trades

While we share many recommendations and ideas with the public, certain moves are hidden from everyone but selected members of our portfolio services. Would you like to peek behind the curtain today and view them?

Starting now, for the next month, I invite you to follow all Zacks' private buys and sells in real time from value to momentum...from stocks under $10 to ETF to option movers...from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors.

Click here for Zacks' secret trade>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Forward Pharma A/S (FWP): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research